Age 0 3 0 3 B-age
> 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Chronic 0 7 15 22 O
aspirin 8 15 23 30 B-treatment
, 15 16 30 31 O
NSAID 17 22 32 37 B-treatment
therapy 23 30 38 45 I-treatment
, 30 31 45 46 O
anticoagulation 32 47 47 62 B-treatment
therapy 48 55 63 70 I-treatment
or 56 58 71 73 O
antiplatelet 59 71 74 86 B-treatment
agents 72 78 87 93 I-treatment

Currently 0 9 94 103 O
enrolled 10 18 104 112 O
in 19 21 113 115 O
other 22 27 116 121 O
interventional 28 42 122 136 B-treatment
trials 43 49 137 143 I-treatment

Endoscopically 0 14 144 158 O
- 14 15 158 159 O
documented 15 25 159 169 O
angiodysplasia 26 40 170 184 B-chronic_disease
and/or 41 47 185 191 O
arteriovenous 48 61 192 205 B-chronic_disease
malformations 62 75 206 219 I-chronic_disease
involving 76 85 220 229 O
the 86 89 230 233 O
small 90 95 234 239 O
bowel 96 101 240 245 O

FCBP 0 4 246 250 O
must 5 9 251 255 O
also 10 14 256 260 O
agree 15 20 261 266 O
to 21 23 267 269 O
ongoing 24 31 270 277 O
pregnancy 32 41 278 287 B-pregnancy
testing 42 49 288 295 O

Females 0 7 296 303 B-gender
of 8 10 304 306 O
childbearing 11 23 307 319 O
potential 24 33 320 329 O
( 34 35 330 331 O
FCBP)† 35 41 331 337 O
must 42 46 338 342 O
have 47 51 343 347 O
a 52 53 348 349 O
negative 54 62 350 358 B-pregnancy
serum 63 68 359 364 I-pregnancy
or 69 71 365 367 I-pregnancy
urine 72 77 368 373 I-pregnancy
pregnancy 78 87 374 383 I-pregnancy
test 88 92 384 388 O
with 93 97 389 393 O
a 98 99 394 395 O
sensitivity 100 111 396 407 O
of 112 114 408 410 O
at 115 117 411 413 O
least 118 123 414 419 O
25 124 126 420 422 B-lower_bound
mIU 127 130 423 426 I-lower_bound
/ 130 131 426 427 I-lower_bound
mL 131 133 427 429 I-lower_bound
within 134 140 430 436 O
10 141 143 437 439 B-lower_bound
- 144 145 440 441 O
14 146 148 442 444 B-upper_bound
days 149 153 445 449 I-upper_bound
prior 154 159 450 455 I-upper_bound
to 160 162 456 458 O
and 163 166 459 462 O
again 167 172 463 468 O
within 173 179 469 475 O
24 180 182 476 478 B-upper_bound
hours 183 188 479 484 I-upper_bound
of 189 191 485 487 O
prescribing 192 203 488 499 O
pomalidomide 204 216 500 512 B-treatment
and 217 220 513 516 O
must 221 225 517 521 O
either 226 232 522 528 O
commit 233 239 529 535 B-contraception_consent
to 240 242 536 538 I-contraception_consent
continued 243 252 539 548 I-contraception_consent
abstinence 253 263 549 559 I-contraception_consent
from 264 268 560 564 I-contraception_consent
heterosexual 269 281 565 577 I-contraception_consent
intercourse 282 293 578 589 I-contraception_consent
or 294 296 590 592 O
begin 297 302 593 598 B-contraception_consent
TWO 303 306 599 602 I-contraception_consent
acceptable 307 317 603 613 I-contraception_consent
methods 318 325 614 621 I-contraception_consent
of 326 328 622 624 I-contraception_consent
birth 329 334 625 630 I-contraception_consent
control 335 342 631 638 I-contraception_consent
, 342 343 638 639 O
one 344 347 640 643 O
highly 348 354 644 650 O
effective 355 364 651 660 O
method 365 371 661 667 O
and 372 375 668 671 O
one 376 379 672 675 O
additional 380 390 676 686 O
effective 391 400 687 696 O
method 401 407 697 703 O
AT 408 410 704 706 O
THE 411 414 707 710 O
SAME 415 419 711 715 O
TIME 420 424 716 720 O
, 424 425 720 721 O
at 426 428 722 724 O
least 429 434 725 730 O
28 435 437 731 733 B-lower_bound
days 438 442 734 738 I-lower_bound
before 443 449 739 745 I-lower_bound
she 450 453 746 749 O
starts 454 460 750 756 O
taking 461 467 757 763 O
pomalidomide 468 480 764 776 O

Hepatic 0 7 777 784 B-chronic_disease
insufficiency 8 21 785 798 I-chronic_disease
, 21 22 798 799 O
bilirubin 23 32 800 809 B-clinical_variable
> 33 34 810 811 O
2.0 35 38 812 815 B-lower_bound
or 39 41 816 818 O
transaminases 42 55 819 832 B-clinical_variable
> 56 57 833 834 O
3.0 58 61 835 838 B-lower_bound
x 62 63 839 840 I-lower_bound
normal 64 70 841 847 I-lower_bound

History 0 7 848 855 O
of 8 10 856 858 O
prior 11 16 859 864 O
thromboembolism 17 32 865 880 B-chronic_disease
with 33 37 881 885 O
known 38 43 886 891 O
thrombophilia 44 57 892 905 B-chronic_disease

Inherited 0 9 906 915 O
or 10 12 916 918 O
significant 13 24 919 930 O
acquired 25 33 931 939 B-chronic_disease
coagulopathy 34 46 940 952 I-chronic_disease
( 47 48 953 954 O
i.e. 48 52 954 958 O
hemophilia 53 63 959 969 B-chronic_disease
, 63 64 969 970 O
advanced 65 73 971 979 O
liver 74 79 980 985 B-chronic_disease
disease 80 87 986 993 I-chronic_disease
) 87 88 993 994 O

Known 0 5 995 1000 O
hypersensitivity 6 22 1001 1017 O
to 23 25 1018 1020 O
thalidomide 26 37 1021 1032 B-allergy_name
or 38 40 1033 1035 O
lenalidomide 41 53 1036 1048 B-allergy_name

Normal 0 6 1049 1055 B-clinical_variable
prothrombin 7 18 1056 1067 I-clinical_variable
( 19 20 1068 1069 I-clinical_variable
PT 20 22 1069 1071 I-clinical_variable
) 22 23 1071 1072 I-clinical_variable
and 24 27 1073 1076 O
activated 28 37 1077 1086 B-clinical_variable
partial 38 45 1087 1094 I-clinical_variable
thromboplastin 46 60 1095 1109 I-clinical_variable
time 61 65 1110 1114 I-clinical_variable
( 66 67 1115 1116 I-clinical_variable
aPTT 67 71 1116 1120 I-clinical_variable
) 71 72 1120 1121 I-clinical_variable

Peripheral 0 10 1122 1132 B-chronic_disease
neuropathy 11 21 1133 1143 I-chronic_disease
, 21 22 1143 1144 O
as 23 25 1145 1147 O
determined 26 36 1148 1158 O
from 37 41 1159 1163 O
neurologic 42 52 1164 1174 O
consultation 53 65 1175 1187 O

Platelet 0 8 1188 1196 B-clinical_variable
count 9 14 1197 1202 I-clinical_variable
≥ 15 16 1203 1204 O
125,000/µl 17 27 1205 1215 B-lower_bound

Pregnancy 0 9 1216 1225 B-pregnancy

Previous 0 8 1226 1234 B-treatment
treatment 9 18 1235 1244 I-treatment
with 19 23 1245 1249 I-treatment
Thalidomide 24 35 1250 1261 I-treatment
or 36 38 1262 1264 I-treatment
other 39 44 1265 1270 I-treatment
imid 45 49 1271 1275 I-treatment
drugs 50 55 1276 1281 I-treatment
within 56 62 1282 1288 O
previous 63 71 1289 1297 B-upper_bound
12 72 74 1298 1300 I-upper_bound
months 75 81 1301 1307 I-upper_bound

Recurrent 0 9 1308 1317 O
bleeding 10 18 1318 1326 O
after 19 24 1327 1332 O
at 25 27 1333 1335 O
least 28 33 1336 1341 O
one 34 37 1342 1345 B-lower_bound
previous 38 46 1346 1354 B-treatment
interventional 47 61 1355 1369 I-treatment
endoscopic 62 72 1370 1380 I-treatment
procedure 73 82 1381 1390 I-treatment

Renal 0 5 1391 1396 B-chronic_disease
insufficiency 6 19 1397 1410 I-chronic_disease
, 19 20 1410 1411 O
serum 21 26 1412 1417 B-clinical_variable
creatinine 27 37 1418 1428 I-clinical_variable
> 38 39 1429 1430 O
2.0 40 43 1431 1434 B-lower_bound
mg 44 46 1435 1437 I-lower_bound
/ 46 47 1437 1438 I-lower_bound
dl 47 49 1438 1440 I-lower_bound

Transfusion 0 11 1441 1452 B-treatment
of 12 14 1453 1455 O
at 15 17 1456 1458 O
least 18 23 1459 1464 O
4 24 25 1465 1466 B-lower_bound
units 26 31 1467 1472 I-lower_bound
of 32 34 1473 1475 I-lower_bound
blood 35 40 1476 1481 I-lower_bound
and/or 41 47 1482 1488 O
four 48 52 1489 1493 O
doses 53 58 1494 1499 O
of 59 61 1500 1502 O
intravenous 62 73 1503 1514 B-treatment
iron 74 78 1515 1519 I-treatment
over 79 83 1520 1524 O
the 84 87 1525 1528 O
preceding 88 97 1529 1538 B-lower_bound
four 98 102 1539 1543 I-lower_bound
months 103 109 1544 1550 I-lower_bound

Underlying 0 10 1551 1561 O
hypoproliferative 11 28 1562 1579 B-chronic_disease
anemia 29 35 1580 1586 I-chronic_disease
( 36 37 1587 1588 O
i.e. 37 41 1588 1592 O
myelodysplasia 42 56 1593 1607 B-cancer
) 56 57 1607 1608 O

WBC 0 3 1609 1612 B-clinical_variable
≥ 4 5 1613 1614 O
4,000/µl 6 14 1615 1623 B-lower_bound

